Marc Thurner

CEO at mimiX Biotherapeutics Ltd

Bern, Berne, Switzerland

About

We provide a Point-Of-Care, cost efficient Tissue Engineering approach to regenerative, patient-tailored precision medicine. We focus on clinical indications performed in the operating theater by providing patient accessibility. At the heart of this revolutionary approach is a proprietary bio-processing technology: "Sound Induced Morphogenesis " - SIM

Experience

  • Chief Executive Officer at mimiX Biotherapeutics
    Jun 2019 - Present · 7 yrs 1 mo

  • CEO & Founder at REGENHU
    Oct 2007 - May 2019 · 11 yrs 8 mos

    Pioneering bioprinting

  • CEO at Delta Robotics GmbH
    2007 - 2011 · 4 yrs